Vogenx Inc.(VOGX)

Biotechnology · Raleigh, NC

$16.63-0.52 (-3.06%)

Delayed quote: Oct 6, 2026, 3:50 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T19:54:26.285Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:54:26.285Z.

Quote observation: 2026-10-06T19:50:14.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow: N/A
Quote market capitalization: 231,181,315

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

VOGX Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

VOGX Competitors' Operating Cash Flow Yield

VOGX

Vogenx Inc.

Current

Market Cap

$231.18M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IFRX

InflaRx N.V.

vs VOGX

Market Cap

$231.25M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGNX

MacroGenics, Inc.

vs VOGX

Market Cap

$233.28M

Operating Cash Flow Yield

N/A

TTM Avg

1.61%

3Y Avg

1.61%

5Y Avg

1.61%

BIOA

BioAge Labs Inc.

vs VOGX

Market Cap

$233.62M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAUT

Nautilus Biotechnolgy, Inc.

vs VOGX

Market Cap

$228.42M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDSX

Biodesix, Inc.

vs VOGX

Market Cap

$228.27M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GLSI

Greenwich LifeSciences, Inc.

vs VOGX

Market Cap

$231.62M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SIGA

SIGA Technologies, Inc.

vs VOGX

Market Cap

$234.90M

Operating Cash Flow Yield

N/A

TTM Avg

17.96%

3Y Avg

12.82%

5Y Avg

11.02%

UTMD

Utah Medical Products, Inc.

vs VOGX

Market Cap

$234.98M

Operating Cash Flow Yield

5.04%

TTM Avg

6.66%

3Y Avg

7.54%

5Y Avg

7.09%

AKBA

Akebia Therapeutics, Inc.

vs VOGX

Market Cap

$236.17M

Operating Cash Flow Yield

17.59%

TTM Avg

15.21%

3Y Avg

15.21%

5Y Avg

15.21%

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Vogenx Inc. (VOGX)	$231.18M	N/A	N/A	N/A	N/A
InflaRx N.V. (IFRX)vs ›	$231.25M	N/A	N/A	N/A	N/A
MacroGenics, Inc. (MGNX)vs ›	$233.28M	N/A	1.61%	1.61%	1.61%
BioAge Labs Inc. (BIOA)vs ›	$233.62M	N/A	N/A	N/A	N/A
Nautilus Biotechnolgy, Inc. (NAUT)vs ›	$228.42M	N/A	N/A	N/A	N/A
Biodesix, Inc. (BDSX)vs ›	$228.27M	N/A	N/A	N/A	N/A
Greenwich LifeSciences, Inc. (GLSI)vs ›	$231.62M	N/A	N/A	N/A	N/A
SIGA Technologies, Inc. (SIGA)vs ›	$234.90M	N/A	17.96%	12.82%	11.02%
Utah Medical Products, Inc. (UTMD)vs ›	$234.98M	5.04%	6.66%	7.54%	7.09%
Akebia Therapeutics, Inc. (AKBA)vs ›	$236.17M	17.59%	15.21%	15.21%	15.21%

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

VOGX Operating Cash Flow Yield Metrics

VOGX Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics